Smoking associated with major urologic cancer surgical complications
the ONA take:
According to a study presented at the 2015 annual meeting of the American Urological Association in New Orleans, Louisiana, researchers have found that smokers and previous smokers are more likely to experience complications during and after major urologic cancer surgery and that quitting smoking for even just 1 year significantly improves surgical outcomes.
For the study, researchers identified 9,014 patients who underwent surgery for bladder, kidney, or prostate cancer from the American College of Surgeons National Surgical Quality Improvement Program database and identified.
Results showed current smokers had an increased risk for pulmonary and kidney complications and longer duration of hospitalization after prostate cancer surgery. In addition, patients with bladder cancer who currently smoked had an increased risk for requiring further surgery and former smokers had an increased risk for readmission.
Patients with prostate cancer who had not smoked for at least 1 year prior to surgery had a similar risk for surgical complications as non-smokers and had a significantly lower risk than current smokers.
The findings suggest that health care providers should motivate patients to quit smoking prior to undergoing major surgery in order to reduce the risk for complications.
Smokers and previous smokers are more likely to experience complications during and after major urologic cancer surgery.
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
- FDA Grants Approval to Novel Treatment for Hairy Cell Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|